Berodual F UDV Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Adverse Reactions

Summary of the safety profile: Many of the listed undesirable effects can be assigned to the anticholinergic and beta-adrenergic properties of fenoterol hydrobromide/ipratropium bromide (Berodual F UDV). As with all inhalation therapy fenoterol hydrobromide/ipratropium bromide (Berodual F UDV) may show symptoms of local irritation.
The most frequent side effects reported in clinical trials were cough, dry mouth, headache, tremor, pharyngitis, nausea, dizziness, dysphonia, tachycardia, palpitations, vomiting, blood pressure systolic increased and nervousness.
Tabulated summary of adverse reactions: The following adverse reactions have been reported during use of fenoterol hydrobromide/ipratropium bromide (Berodual F UDV) in clinical trials and during the post-marketing experience. (See Table.)

Click on icon to see table/diagram/image

View ADR Reporting Link

Berodual F UDV Adverse Reactions

ipratropium + fenoterol

Manufacturer:

Laboratoire Unither

Distributor:

Boehringer Ingelheim